Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19147,920,1.35 [1.17-1.55],4.3781328823235086e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,18387,291,1.94 [1.56-2.41],3.580993692628933e-09
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21702,181,1.31 [0.97-1.78],0.0788152518106281
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13450,1089,1.70 [1.49-1.94],1.3618973614794433e-15
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21656,135,1.44 [1.02-2.01],0.0361086942865346
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19198,96,1.99 [1.37-2.89],0.000311245289679
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23127,134,1.44 [1.03-2.02],0.0353210773641485
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23114,90,0.82 [0.50-1.34],0.4364278663102273
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18701,73,1.71 [1.09-2.69],0.0196426294149778
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21961,133,1.73 [1.25-2.39],0.0008872077048699
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21916,88,1.84 [1.25-2.71],0.0019237754629872
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23235,69,1.07 [0.63-1.81],0.7946011863786396
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23268,68,1.52 [0.96-2.42],0.0731395816458525
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23265,65,1.45 [0.89-2.35],0.1314381578513618
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,22761,61,1.05 [0.60-1.84],0.8571773762920242
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21637,441,1.27 [1.04-1.56],0.0191563060103794
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21335,139,1.44 [1.02-2.02],0.037348309466387
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21516,320,1.23 [0.97-1.56],0.0840253163777686
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",16733,103,1.35 [0.90-2.00],0.1431462182218391
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16694,64,0.67 [0.36-1.26],0.2138295782272976
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17035,405,0.91 [0.72-1.14],0.4014280545900143
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17047,417,0.89 [0.70-1.13],0.3336883865085936
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",9563,384,1.14 [0.90-1.44],0.269229699514228
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7660,209,0.67 [0.48-0.94],0.0213002338474897
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16687,57,0.60 [0.31-1.16],0.1280156064355081
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19871,781,1.44 [1.24-1.67],1.4356832712455951e-06
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21724,473,1.17 [0.96-1.42],0.1232645122766019
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22731,158,1.02 [0.72-1.45],0.8931449422986228
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23321,152,1.47 [1.07-2.01],0.016022148003789
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,22996,86,1.47 [0.97-2.24],0.0714750611549806
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23329,97,1.25 [0.82-1.90],0.2996615152210019
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Stomach,23384,71,1.17 [0.70-1.93],0.5513952277290606
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,23144,297,0.81 [0.61-1.06],0.12032066169933
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23365,102,0.68 [0.42-1.10],0.1148503308198979
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23371,85,0.71 [0.43-1.20],0.2050410585141877
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23282,59,1.03 [0.58-1.82],0.930575573491822
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma, any site",23285,58,0.96 [0.53-1.74],0.90593628905818
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi,23223,149,0.90 [0.62-1.31],0.5752983355416423
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23362,64,1.16 [0.68-1.97],0.5910593557191187
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Other benign neoplasms of skin,23241,177,0.98 [0.70-1.37],0.8914531856193764
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of breast,12195,44,0.92 [0.46-1.84],0.8071217711352651
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Leiomyoma of uterus,12049,309,1.05 [0.80-1.36],0.7403885429752697
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21790,197,1.50 [1.14-1.98],0.00434139497158
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21249,359,1.71 [1.40-2.09],1.5650442307023066e-07
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21249,359,1.71 [1.40-2.09],1.5650442307023066e-07
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18667,573,1.66 [1.40-1.96],3.0119805158260032e-09
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22761,59,0.74 [0.39-1.39],0.345560443104281
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23034,63,1.12 [0.65-1.91],0.6815755386186395
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,16908,1665,1.27 [1.14-1.42],1.851839164577161e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21632,648,1.11 [0.93-1.32],0.2435161307268096
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20550,157,2.75 [2.13-3.56],1.3201924646897548e-14
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21753,170,1.88 [1.43-2.47],6.248510163752957e-06
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20536,143,2.65 [2.01-3.47],2.629151137162826e-12
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21178,785,2.30 [2.01-2.63],9.779443105474938e-34
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21152,759,2.31 [2.02-2.65],2.452533794452144e-33
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21478,189,1.26 [0.92-1.72],0.1455042119030559
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21477,188,1.26 [0.92-1.72],0.145496121131181
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16725,1482,1.20 [1.07-1.35],0.0018438170783656
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15435,192,1.38 [1.03-1.85],0.0306906743881327
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,16615,1372,1.20 [1.06-1.35],0.0034095126319886
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15300,57,1.61 [0.98-2.64],0.0612670402216859
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15334,91,2.71 [1.99-3.69],2.5469714787577225e-10
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Any mental disorder,19135,544,1.18 [0.98-1.41],0.0815551631489495
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18753,162,1.88 [1.41-2.51],1.671149865496572e-05
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23013,114,2.18 [1.59-2.98],1.2779359320707749e-06
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23074,85,2.20 [1.54-3.15],1.481821138977016e-05
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21815,34,1.35 [0.67-2.72],0.3954359665785429
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23304,34,1.32 [0.66-2.64],0.438443523972442
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",18625,34,1.32 [0.65-2.67],0.4389542877925005
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Alcohol dependence,21823,42,2.32 [1.43-3.77],0.0006416755415874
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Smoking dependency,21748,50,1.14 [0.62-2.09],0.6725754689725585
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18627,36,0.72 [0.33-1.59],0.415456111526664
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",18855,264,0.94 [0.72-1.25],0.6870854596663749
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Depression,21906,234,0.93 [0.70-1.25],0.646899690299714
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Depression or dysthymia,18491,201,1.04 [0.77-1.42],0.7853480647630078
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",18702,111,0.87 [0.56-1.34],0.530466492038304
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Other anxiety disorders,21962,64,0.56 [0.30-1.04],0.064157906752412
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Neurological diseases,18995,1516,1.20 [1.07-1.35],0.0017808960513631
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16615,106,1.06 [0.69-1.65],0.7841712278683686
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23289,81,0.80 [0.48-1.35],0.4064183653415266
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22037,476,1.26 [1.04-1.53],0.0161307497993892
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Epilepsy,21697,136,1.31 [0.93-1.86],0.1258097153018906
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Migraine,21620,59,0.90 [0.50-1.64],0.7360177290930165
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23147,53,0.95 [0.51-1.76],0.8773330832656567
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22195,120,1.19 [0.81-1.76],0.3761661053082847
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,21722,161,1.40 [1.03-1.90],0.030937489929838
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,22845,120,1.46 [1.04-2.06],0.0291584903638466
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22162,723,1.14 [0.97-1.33],0.1179986369527665
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21545,106,0.72 [0.45-1.15],0.1701409976920931
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21883,444,1.25 [1.02-1.52],0.0280892943023812
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22995,79,0.88 [0.53-1.47],0.6200928918824076
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hemiplegia,22976,60,1.14 [0.66-1.96],0.6476660588727194
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,22820,121,1.56 [1.11-2.21],0.011082941963811
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22512,428,1.18 [0.96-1.44],0.1219028356246369
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22343,259,1.25 [0.97-1.62],0.0827552824611163
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22146,62,1.27 [0.76-2.13],0.3571507067476408
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22221,137,1.18 [0.82-1.69],0.3652467288781785
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22191,107,1.10 [0.73-1.68],0.6384497645818379
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17892,260,1.30 [1.01-1.68],0.0451032003855268
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18248,616,1.45 [1.23-1.70],1.0883260468663728e-05
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,21965,308,1.51 [1.21-1.88],0.000310122309285
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22959,82,2.22 [1.55-3.19],1.2963396062391182e-05
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2633,82,1.48 [1.03-2.14],0.0360097044024321
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20408,82,2.62 [1.80-3.80],4.0355591769600523e-07
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22379,139,1.34 [0.95-1.89],0.0929400760331911
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22316,76,1.20 [0.74-1.94],0.4698312188724163
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22448,80,1.04 [0.63-1.69],0.8897184134962208
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22689,100,0.96 [0.62-1.50],0.8717012216202004
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23289,143,1.03 [0.71-1.49],0.888870918463709
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22146,111,0.80 [0.52-1.26],0.3376958003458008
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,14401,4620,1.51 [1.39-1.64],5.741334347788935e-22
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22423,97,2.40 [1.75-3.30],6.603067435926128e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",15267,3243,1.40 [1.28-1.53],6.169660495703633e-13
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertension,15311,3287,1.40 [1.28-1.54],2.206198882892123e-13
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12136,112,2.29 [1.63-3.21],1.7163379659834624e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20474,1844,1.27 [1.15-1.42],5.009094082352924e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,19727,1097,1.21 [1.06-1.38],0.0056397408539007
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21985,349,1.33 [1.07-1.65],0.0106877867481433
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22337,701,1.16 [0.98-1.36],0.0804240165807386
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23217,132,1.00 [0.68-1.46],0.9805789540936818
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19066,436,1.20 [0.97-1.48],0.0867859215294003
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20101,1496,1.31 [1.17-1.46],3.965022066331177e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22227,137,1.13 [0.79-1.63],0.4981101039448494
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22450,280,1.13 [0.88-1.45],0.3483249196047809
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22207,117,2.67 [2.03-3.53],3.6151544498999808e-12
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22208,118,2.65 [2.01-3.50],5.1370293612113584e-12
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12137,113,2.81 [2.10-3.77],4.008542513781521e-12
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17168,71,3.35 [2.40-4.69],1.4339210918860689e-12
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,17269,172,2.44 [1.90-3.15],5.055955753826158e-12
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9119,144,1.69 [1.20-2.39],0.0028788279658345
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9668,693,3.18 [2.73-3.71],2.442844537748641e-49
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,17191,94,2.52 [1.81-3.51],4.3741865259339335e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17221,124,2.88 [2.21-3.75],6.824238657347584e-15
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21720,295,2.74 [2.29-3.29],8.554796335289532e-28
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22093,200,1.36 [1.02-1.80],0.0352117900175446
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22128,180,1.49 [1.12-1.99],0.0062663366854867
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22235,160,1.47 [1.08-2.00],0.0145122747813949
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21727,108,1.38 [0.94-2.03],0.0956877279516134
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21797,178,1.50 [1.12-2.00],0.00644511096633
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21653,165,1.20 [0.86-1.67],0.2775559562087464
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21631,143,1.27 [0.90-1.79],0.17473375256965
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23104,137,1.20 [0.85-1.70],0.3059637755456839
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Varicose veins,22003,515,1.13 [0.93-1.37],0.2304414659296485
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypotension,21682,121,1.56 [1.10-2.22],0.0127520896859465
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17233,2173,1.45 [1.32-1.60],4.281538033037444e-14
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23220,77,1.63 [1.08-2.48],0.020971289130457
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20800,264,1.70 [1.35-2.14],6.399623944650861e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20772,236,1.66 [1.30-2.13],5.085192300560956e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22096,290,1.72 [1.39-2.13],6.655065981828492e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22087,281,1.71 [1.37-2.12],1.5343518768093453e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22650,552,1.04 [0.86-1.26],0.6700652259358804
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22189,91,1.00 [0.63-1.59],0.98648291661467
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Nasal polyp,22238,140,1.07 [0.74-1.54],0.723857345783286
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22451,353,1.07 [0.85-1.35],0.556233245835145
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22233,135,0.91 [0.62-1.35],0.6445213745557008
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7421,76,0.97 [0.56-1.69],0.9089210936546644
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20249,1147,1.43 [1.26-1.62],1.3533371798088808e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Early onset COPD,21709,246,1.76 [1.38-2.23],3.89575487375633e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21762,299,1.85 [1.50-2.29],1.4631458470156673e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21762,299,1.85 [1.50-2.29],1.4631458470156673e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21674,873,1.31 [1.14-1.51],0.0001978011444873
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Asthma,15207,873,1.44 [1.25-1.67],8.146392819451589e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14810,873,1.48 [1.28-1.71],1.5799541454430769e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15198,864,1.45 [1.25-1.68],7.686609485164474e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22810,125,1.50 [1.06-2.12],0.0211122589497669
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21725,97,1.44 [0.96-2.15],0.0765530832701455
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22907,97,1.43 [0.96-2.13],0.0783880850554681
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21718,90,1.26 [0.82-1.96],0.2940339013414698
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural effusion,20547,145,1.87 [1.39-2.52],3.433350799931493e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,20701,299,1.79 [1.44-2.21],1.1909343246631059e-07
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21683,135,1.82 [1.34-2.47],0.0001269495779473
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15095,6518,1.04 [0.96-1.12],0.3174611805438543
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22931,344,1.31 [1.05-1.64],0.0152678147331795
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23382,43,1.11 [0.57-2.15],0.7615038925950823
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impacted teeth,23384,39,1.30 [0.67-2.51],0.4334209224277263
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Dental caries,22679,92,1.70 [1.16-2.48],0.0066167454675264
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22680,93,1.13 [0.72-1.76],0.5927939752902456
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23378,47,0.97 [0.50-1.88],0.9319876682247084
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22689,102,1.13 [0.74-1.72],0.5626133121403301
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22413,92,1.11 [0.71-1.75],0.6450823670969879
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23273,60,1.07 [0.61-1.87],0.8245752662835768
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16495,346,1.22 [0.97-1.54],0.0845892564249075
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18752,2603,1.03 [0.94-1.14],0.4890606651863899
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophagitis,16560,411,1.04 [0.84-1.30],0.7064801013595451
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16993,844,0.92 [0.78-1.08],0.2869890607556769
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16237,88,1.51 [0.98-2.30],0.0592585160676465
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16432,283,1.21 [0.94-1.57],0.1364701292710834
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16233,84,0.65 [0.38-1.12],0.1186198811874888
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,16355,206,1.28 [0.95-1.71],0.1001130687575052
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,16296,147,1.23 [0.86-1.75],0.252479618646968
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23205,101,1.18 [0.78-1.79],0.427269179489671
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,16297,148,1.25 [0.88-1.78],0.2048655721794482
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17147,998,1.08 [0.93-1.24],0.3036114662029997
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,23247,90,0.92 [0.57-1.49],0.7456108029840272
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16639,490,1.04 [0.85-1.28],0.6914201430583509
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16377,228,0.96 [0.71-1.30],0.7873806891746613
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23251,122,1.14 [0.78-1.67],0.5030213354019916
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,23234,77,1.01 [0.61-1.67],0.970439089016022
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Hernia,19723,2095,0.94 [0.85-1.04],0.2554426262889567
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,18430,802,0.92 [0.78-1.08],0.3012065437951977
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,17765,137,1.20 [0.85-1.71],0.2962210380247501
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ventral hernia,17738,110,1.29 [0.88-1.89],0.1941413337104925
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18772,1144,0.90 [0.78-1.03],0.1252147854076729
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22305,770,1.29 [1.11-1.50],0.0008679894405691
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,17120,2357,1.10 [1.00-1.21],0.0559115868402297
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23027,44,1.50 [0.83-2.70],0.1755404389850099
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23320,58,1.67 [1.03-2.72],0.0369245156272456
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn disease,21593,58,1.70 [1.05-2.77],0.0309543320345997
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21578,43,2.06 [1.23-3.45],0.0060508499731027
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23238,143,1.35 [0.96-1.89],0.0811571554482488
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21678,143,1.37 [0.98-1.92],0.0654108270648934
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21668,133,1.37 [0.97-1.95],0.0772968186175232
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22173,638,1.26 [1.07-1.49],0.0064861357933963
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22164,629,1.25 [1.05-1.47],0.0104647758239328
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14892,129,0.90 [0.60-1.35],0.6044485861133566
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal stricture,22782,129,0.89 [0.60-1.34],0.5836824684956624
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14846,83,0.95 [0.58-1.56],0.8320698714451955
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15679,916,1.10 [0.95-1.28],0.1964125580607539
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14919,156,1.07 [0.75-1.52],0.7114640801419675
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15089,326,1.12 [0.88-1.43],0.3423208781125083
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Constipation,21252,293,1.12 [0.87-1.44],0.3872236571677967
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22889,95,1.02 [0.65-1.60],0.922567518653902
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14869,106,1.00 [0.65-1.55],0.9899808885357008
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14818,55,1.14 [0.64-2.03],0.6492006132777237
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15743,980,1.10 [0.95-1.27],0.208176869195976
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,15130,367,1.26 [1.01-1.56],0.0413096977454896
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22873,79,1.04 [0.64-1.70],0.8639755504591513
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of liver,22474,128,3.14 [2.44-4.05],1.0090811492581025e-18
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,22419,73,2.94 [2.10-4.13],4.3823378389941965e-10
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21873,736,1.09 [0.93-1.28],0.2807807616081117
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,21736,599,0.91 [0.75-1.10],0.3274212486740312
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholecystitis,21260,123,1.30 [0.90-1.89],0.1568043415573201
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21195,58,1.92 [1.21-3.02],0.0051493777180733
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21213,76,1.31 [0.82-2.08],0.2529226125779242
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23193,76,1.31 [0.82-2.08],0.2579326763844677
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21857,345,1.06 [0.84-1.35],0.6097969927177911
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21588,76,0.49 [0.27-0.88],0.0169652239107312
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Coeliac disease,21577,65,0.45 [0.23-0.85],0.0136765826279263
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21570,58,1.44 [0.86-2.40],0.1638250952925681
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21727,215,1.13 [0.85-1.52],0.4025987819499569
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,GI-bleeding,21718,206,1.14 [0.84-1.53],0.4006858920693276
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19632,1628,1.19 [1.07-1.34],0.0018430983089823
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22843,107,0.83 [0.53-1.30],0.4148134977160301
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22964,442,0.96 [0.78-1.19],0.7349670564875523
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,21271,630,1.26 [1.06-1.49],0.0087967313486271
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22318,393,1.39 [1.13-1.70],0.001650347558829
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21996,71,1.70 [1.10-2.64],0.0171005227901652
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22206,281,1.44 [1.14-1.82],0.0025593226584023
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23067,98,1.50 [1.02-2.20],0.0410346576898024
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23040,71,1.50 [0.95-2.35],0.0796025381127184
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23027,58,1.61 [1.00-2.61],0.052312837659317
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22945,80,1.02 [0.62-1.68],0.944166353670316
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22943,78,1.00 [0.60-1.67],0.9919087411162296
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22571,49,0.71 [0.36-1.40],0.320032754346557
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22892,370,0.98 [0.78-1.24],0.8950316405083745
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20758,117,1.32 [0.91-1.94],0.1478035921395641
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20745,104,1.31 [0.87-1.96],0.1933559818405757
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20712,71,1.14 [0.68-1.91],0.612771564133418
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20872,231,1.23 [0.93-1.63],0.1394439778632704
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20853,212,1.22 [0.91-1.64],0.1777142282606404
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15276,4473,1.04 [0.96-1.13],0.2999810455756083
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,16889,2789,1.03 [0.94-1.14],0.4766116841350256
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20732,1311,1.10 [0.97-1.24],0.1374959843893608
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14287,187,1.81 [1.38-2.37],1.919078828391574e-05
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14693,593,1.37 [1.15-1.63],0.0003513941665203
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22859,181,1.73 [1.32-2.27],7.916091793942344e-05
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22864,165,1.84 [1.40-2.42],1.511209884493048e-05
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15755,1655,0.95 [0.84-1.07],0.3854584486552259
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",18313,1655,0.90 [0.80-1.01],0.0829652759634655
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14195,95,1.60 [1.09-2.37],0.0174230714865567
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22599,92,1.59 [1.08-2.32],0.0179736746899653
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14393,293,1.08 [0.83-1.40],0.552147974114646
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14221,121,1.10 [0.74-1.63],0.6466719087660684
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14541,441,0.93 [0.74-1.16],0.5229674576884947
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23158,218,1.09 [0.81-1.46],0.5598909644032818
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14838,738,0.95 [0.80-1.13],0.5629964723292881
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14671,571,1.05 [0.86-1.26],0.6466078457264866
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15445,1345,1.00 [0.88-1.14],0.977298977689326
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14193,93,1.19 [0.76-1.85],0.4539168032658522
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14399,299,0.86 [0.65-1.13],0.2865337835431633
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14178,78,1.07 [0.65-1.77],0.7898615874525434
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14191,91,0.57 [0.33-0.96],0.0359335893884705
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14548,448,0.97 [0.78-1.20],0.7732977201337419
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14505,405,0.91 [0.72-1.15],0.4436025944823256
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17576,276,1.02 [0.78-1.33],0.9017106162308928
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22648,106,0.79 [0.50-1.24],0.3063629521295534
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22613,71,0.98 [0.58-1.68],0.9525150669808856
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19343,78,1.08 [0.66-1.76],0.7716911698056979
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19643,378,1.00 [0.79-1.25],0.9725966587670613
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20224,959,0.90 [0.78-1.05],0.1862718323645823
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19510,245,0.86 [0.64-1.15],0.3075395818771171
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19382,117,1.27 [0.87-1.86],0.2129289895931858
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19969,704,0.88 [0.74-1.05],0.1538068186633344
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19308,43,1.28 [0.69-2.40],0.4343455187772748
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19484,219,0.85 [0.62-1.16],0.2992689191866655
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19354,89,0.83 [0.51-1.37],0.4717428618264284
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19351,86,0.72 [0.43-1.20],0.2042784239677084
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19397,132,0.93 [0.63-1.37],0.7084368660308282
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19326,61,0.87 [0.48-1.57],0.6451968929045739
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19557,292,0.81 [0.62-1.07],0.1441909316331919
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19759,338,1.14 [0.90-1.44],0.2774263550354467
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19505,84,1.26 [0.80-1.97],0.3190213152685135
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19540,119,1.13 [0.76-1.67],0.540229789783927
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19509,88,0.90 [0.55-1.47],0.6651882623108654
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19463,42,1.25 [0.66-2.37],0.4841279752861221
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19588,167,0.76 [0.53-1.10],0.1513869723660006
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19577,156,0.77 [0.53-1.13],0.1838877117439523
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19719,298,1.01 [0.78-1.31],0.9255511793295774
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19478,57,1.09 [0.61-1.92],0.7762534921157052
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19522,101,1.01 [0.65-1.56],0.9768150555586428
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19563,142,0.97 [0.67-1.41],0.869563914979413
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19473,52,1.31 [0.75-2.30],0.3477101063297533
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",19884,463,1.19 [0.98-1.45],0.0788940930216247
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19613,192,1.48 [1.12-1.96],0.005422068642866
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19678,257,1.14 [0.87-1.48],0.3359057752947185
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,20955,243,0.92 [0.68-1.23],0.5722455917803588
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21153,441,1.03 [0.83-1.27],0.8043900439898486
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20753,41,0.98 [0.49-1.98],0.962181128091453
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20761,49,1.30 [0.72-2.34],0.3809740901732013
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20801,89,1.24 [0.80-1.94],0.3341557116167937
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17039,4124,1.11 [1.02-1.20],0.0123709227327262
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9016,875,0.95 [0.81-1.11],0.5261501473290704
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19608,300,1.61 [1.28-2.01],3.292292850970692e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19391,83,1.17 [0.73-1.88],0.5098969861244547
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19660,65,2.07 [1.34-3.18],0.0009562143542428
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19688,93,1.94 [1.35-2.79],0.000345434304103
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19675,80,2.39 [1.68-3.42],1.47609435364131e-06
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23005,252,1.22 [0.94-1.58],0.1421297582143233
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22773,93,2.11 [1.51-2.96],1.4549435349324648e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22940,187,1.22 [0.91-1.65],0.189295450131974
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22829,76,1.04 [0.63-1.71],0.8736741373333519
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,20414,1219,0.99 [0.87-1.13],0.8909950867180407
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,19310,115,1.07 [0.71-1.61],0.7517150293648456
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19291,96,1.24 [0.81-1.91],0.325420624013278
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19567,372,0.93 [0.73-1.18],0.564741241292129
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19339,144,1.17 [0.82-1.67],0.3999112571427496
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19938,743,1.00 [0.85-1.18],0.9968557546712022
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8641,500,0.92 [0.75-1.14],0.4521675974817416
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8212,71,0.66 [0.37-1.17],0.1515488982364506
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8204,63,1.27 [0.78-2.08],0.3396008416275973
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8213,72,1.18 [0.73-1.90],0.5061495472933514
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8237,96,0.55 [0.33-0.92],0.0215767386895833
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8254,113,1.08 [0.72-1.60],0.7210466954540311
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12085,231,1.14 [0.85-1.52],0.3941149954291204
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11931,77,0.88 [0.51-1.51],0.6352702778137602
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,11935,81,1.13 [0.69-1.86],0.6144602850745058
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11912,58,1.17 [0.66-2.07],0.5861092336234327
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12058,166,0.88 [0.61-1.27],0.4883481556805223
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,11942,50,1.00 [0.52-1.92],0.9948026878832472
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11949,57,0.72 [0.38-1.37],0.3158108799594966
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11174,1827,1.00 [0.89-1.12],0.9336166374461792
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9410,63,0.79 [0.43-1.45],0.4370637477241589
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9398,51,0.54 [0.27-1.11],0.094851318348691
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9840,493,0.77 [0.62-0.97],0.0239422273049704
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9454,107,0.91 [0.58-1.43],0.6745349251949215
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9833,486,1.03 [0.83-1.27],0.8115793474361663
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9497,150,1.04 [0.71-1.51],0.8568781382175104
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9569,222,1.09 [0.81-1.48],0.5622038237083729
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9364,17,0.41 [0.12-1.49],0.1761892951799754
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9394,47,1.05 [0.54-2.03],0.8835373547897563
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",12208,63,1.03 [0.58-1.82],0.9237208323602076
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,12210,58,1.15 [0.65-2.05],0.6303636306402087
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,12216,29,1.11 [0.50-2.49],0.7954966333231078
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",12214,33,0.96 [0.44-2.12],0.9247883208627798
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9421,74,1.13 [0.67-1.89],0.6545597952317246
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9400,53,1.51 [0.87-2.65],0.1458403916882965
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9415,68,1.77 [1.12-2.80],0.0136980939932751
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,12215,87,0.95 [0.57-1.56],0.8292413846849891
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9542,195,0.98 [0.70-1.37],0.8931035329392716
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9438,91,1.02 [0.63-1.64],0.9468365278793248
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",12217,37,1.23 [0.60-2.51],0.5686245580102078
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9459,112,1.26 [0.84-1.90],0.2685856575320159
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9394,47,1.24 [0.66-2.32],0.5022908488282778
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9987,640,1.16 [0.97-1.39],0.1073088566339097
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22826,87,1.58 [1.06-2.36],0.0250612922135036
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19915,670,1.21 [1.02-1.43],0.0258767416976495
